This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

Hodgkin lymphoma accounts for less than 1% of all cancers in the UK (2010)

The annual incidence of Hodgkin lymphoma (HL) in the UK is 2.7/100,000

  • in 2010, there were 1,866 new cases of Hodgkin lymphoma in the UK
    • 1,072 (57%) in males and 794 (43%) in females, giving a male:female ratio of more than 13:10
  • there is a peak in incidence in young adults ages 20-34 years with a further peak observed >70 years.
  • over half (55%) of men and women diagnosed with Hodgkin lymphoma present at stage I or II. For around a sixth (17%) of patients, the stage is not known.

There is wide international variation in the incidence of Hodgkin lymphoma

  • the variation is similar for males and females
  • the highest rates are in Southern Europe and Northern America
  • in many parts of Asia and Africa, incidence rates for Hodgkin lymphoma are 1 per 100,000 population, with the world average being around 1.2 per 100,000 for males and 0.8 per 100,000 for females (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.